Antje Lindemann

1.2k total citations
12 papers, 536 citations indexed

About

Antje Lindemann is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Antje Lindemann has authored 12 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Antje Lindemann's work include Cancer-related Molecular Pathways (5 papers), Nanoparticle-Based Drug Delivery (2 papers) and DNA Repair Mechanisms (2 papers). Antje Lindemann is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Nanoparticle-Based Drug Delivery (2 papers) and DNA Repair Mechanisms (2 papers). Antje Lindemann collaborates with scholars based in United States, Germany and Japan. Antje Lindemann's co-authors include Jeffrey N. Myers, Abdullah A. Osman, Ameeta A. Patel, Hideaki Takahashi, Noriaki Tanaka, Mei Zhao, Yoko Takahashi, Ralph Pries, Barbara Wollenberg and Kerstin Lüdtke‐Buzug and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Dental Research.

In The Last Decade

Antje Lindemann

12 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antje Lindemann United States 9 315 210 130 87 49 12 536
Haixia Fan China 12 229 0.7× 132 0.6× 110 0.8× 165 1.9× 74 1.5× 20 530
Sankar Jagadeeshan India 14 267 0.8× 204 1.0× 80 0.6× 84 1.0× 45 0.9× 32 585
Wenqi Jiang China 14 395 1.3× 183 0.9× 128 1.0× 130 1.5× 60 1.2× 22 796
Monica Cojoc Germany 10 487 1.5× 434 2.1× 330 2.5× 71 0.8× 151 3.1× 11 930
Lianji Wen China 12 278 0.9× 141 0.7× 177 1.4× 41 0.5× 28 0.6× 22 455
Qingwen Jiang United States 2 241 0.8× 163 0.8× 139 1.1× 65 0.7× 64 1.3× 3 452
Simin Najafgholian Iran 3 236 0.7× 150 0.7× 213 1.6× 134 1.5× 61 1.2× 5 516
Nick A. Kuburich United States 7 260 0.8× 134 0.6× 117 0.9× 33 0.4× 55 1.1× 14 443
N. V. Krakhmal Russia 8 208 0.7× 234 1.1× 128 1.0× 84 1.0× 45 0.9× 23 511
Yuebo Gan United States 16 410 1.3× 187 0.9× 112 0.9× 63 0.7× 64 1.3× 20 686

Countries citing papers authored by Antje Lindemann

Since Specialization
Citations

This map shows the geographic impact of Antje Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Lindemann more than expected).

Fields of papers citing papers by Antje Lindemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Lindemann. The network helps show where Antje Lindemann may publish in the future.

Co-authorship network of co-authors of Antje Lindemann

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Lindemann. A scholar is included among the top collaborators of Antje Lindemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Lindemann. Antje Lindemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Osman, Abdullah A., Emre Arslan, Chieko Michikawa, et al.. (2023). Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 29(7). 1344–1359. 32 indexed citations
2.
Lindemann, Antje, Ameeta A. Patel, Lin Tang, et al.. (2021). Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Molecular Cancer Therapeutics. 20(7). 1257–1269. 18 indexed citations
3.
Gao, Meng, Antje Lindemann, Li Wang, et al.. (2020). Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis. JCI Insight. 5(23). 40 indexed citations
4.
Lindemann, Antje, Hideaki Takahashi, Ameeta A. Patel, et al.. (2020). Abstract PR08: Inhibition of ATR as a therapeutic strategy to overcome cisplatin resistance in HNSCC. Clinical Cancer Research. 26(12_Supplement_2). PR08–PR08. 1 indexed citations
5.
Lindemann, Antje, Ameeta A. Patel, Natalie L. Silver, et al.. (2019). COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms. Clinical Cancer Research. 25(18). 5650–5662. 102 indexed citations
6.
Tanaka, Noriaki, Abdullah A. Osman, Yoko Takahashi, et al.. (2018). Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncology. 87. 49–57. 106 indexed citations
7.
Lindemann, Antje, Hideaki Takahashi, Ameeta A. Patel, Abdullah A. Osman, & Jeffrey N. Myers. (2018). Targeting the DNA Damage Response in OSCC with TP 53 Mutations. Journal of Dental Research. 97(6). 635–644. 115 indexed citations
8.
Lindemann, Antje, Ameeta A. Patel, Hideaki Takahashi, et al.. (2018). COTI-2, a potent orally available small molecule targeting mutant p53, with promising efficacy as monotherapy and combination treatment in preclinical tumor models.. Journal of Clinical Oncology. 36(15_suppl). 6040–6040. 4 indexed citations
9.
Lindemann, Antje, Ralph Pries, Kerstin Lüdtke‐Buzug, & Barbara Wollenberg. (2015). Biological Properties of Superparamagnetic Iron Oxide Nanoparticles. IEEE Transactions on Magnetics. 51(2). 1–4. 12 indexed citations
10.
Lindemann, Antje, et al.. (2014). Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. International Journal of Nanomedicine. 9. 5025–5025. 45 indexed citations
11.
Tienson, Heather L., Antje Lindemann, Victor Vitvitsky, et al.. (2013). Time line of redox events in aging postmitotic cells. eLife. 2. e00306–e00306. 60 indexed citations
12.
Lindemann, Antje, et al.. (2010). Nanoparticel labelling of stem cell populations in head and neck cancer.. PubMed. 6(2). 143–143. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haixia Fan Breakdown of academic impact, for papers by Sankar Jagadeeshan Breakdown of academic impact, for papers by Wenqi Jiang Breakdown of academic impact, for papers by Monica Cojoc Breakdown of academic impact, for papers by Lianji Wen Breakdown of academic impact, for papers by Qingwen Jiang Breakdown of academic impact, for papers by Simin Najafgholian Breakdown of academic impact, for papers by Nick A. Kuburich Breakdown of academic impact, for papers by N. V. Krakhmal Breakdown of academic impact, for papers by Yuebo Gan
Rankless by CCL
2026